Buspar and Lac-hydrin drug interactions - a phase IV clinical study of FDA data


Drug interactions are reported among people who take Buspar and Lac-hydrin. Common interactions include chest discomfort among females and agitation among males.

The phase IV clinical study analyzes what interactions people who take Buspar and Lac-hydrin have. It is created by eHealthMe based on reports of 19 people who take Buspar and Lac-hydrin from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Nov, 30, 2022

19 people who take Buspar and Lac-hydrin together, and have interactions are studied.

What is Buspar?

Buspar has active ingredients of buspirone hydrochloride. It is often used in stress and anxiety. eHealthMe is studying from 19,100 Buspar users for its effectiveness, alternative drugs and more.

What is Lac-hydrin?

Lac-hydrin has active ingredients of ammonium lactate. eHealthMe is studying from 507 Lac-hydrin users for its effectiveness, alternative drugs and more.

Number of Buspar and Lac-hydrin reports submitted per year:

Buspar and Lac-hydrin drug interactions.

Common Buspar and Lac-Hydrin drug interactions by gender *:


  1. Chest discomfort
  2. Dyspnoea
  3. Hodgkin's disease
  4. Impetigo
  5. Keratoconjunctivitis sicca
  6. Lacrimation increased
  7. Lung disorder
  8. Lymphadenopathy
  9. Neuropathy peripheral
  10. Oral herpes


  1. Agitation
  2. Confusion
  3. Lymphocyte count decreased
  4. Neutrophil count increased
  5. Pneumonia
  6. Anaemia
  7. Chest pain
  8. Dyspnoea exertional
  9. Fatigue
  10. Sinus tachycardia

Common Buspar and Lac-Hydrin drug interactions by age *:








  1. Hodgkin's disease
  2. Impetigo
  3. Keratoconjunctivitis sicca
  4. Lacrimation increased
  5. Lung disorder
  6. Lymphadenopathy
  7. Neuropathy peripheral
  8. Oral herpes
  9. Pneumothorax
  10. Sarcoidosis




  1. Agitation
  2. Diabetes mellitus
  3. Diabetic neuropathy
  4. Drug ineffective
  5. Dyspnoea exertional
  6. Fatigue
  7. Fibromyalgia
  8. Gastrointestinal pain
  9. Hypertension
  10. Non-cardiac chest pain




  1. Pneumonia

Common conditions people have *:

  1. Oropharyngeal Pain: 6 people, 31.58%
  2. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 6 people, 31.58%
  3. Nausea And Vomiting: 5 people, 26.32%
  4. Dissociative Disorder: 5 people, 26.32%
  5. Intervertebral Disc Degeneration (spinal disc degeneration): 5 people, 26.32%
  6. Pain: 5 people, 26.32%
  7. Glossitis (infection of tongue with soreness): 5 people, 26.32%
  8. Depression: 4 people, 21.05%
  9. Urinary Incontinence (inability to control the flow of urine and involuntary urination): 2 people, 10.53%
  10. Hallucination, Auditory (perceiving sounds without auditory stimulus): 2 people, 10.53%

* Approximation only. Some reports may have incomplete information.

Do you take Buspar and Lac-hydrin?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Buspar and Lac-hydrin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Buspar side effects:

Browse all side effects of Buspar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Buspar interactions:

Browse all interactions between Buspar and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on buspirone hydrochloride and ammonium lactate (the active ingredients of Buspar and Lac-hydrin, respectively), and Buspar and Lac-hydrin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Buspar and Lac-hydrin.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: